Skip to main content
OpenTrials

Clinical trial condition

Hemophilia A

Explore clinical trials studying Hemophilia A. Study availability and eligibility vary by location and protocol.

281 public trials 36 recruiting studies
Refine in advanced search Browse all conditions

Hemophilia A trial results

Completed

A Study to Evaluate the Safety, Efficacy, Pharmacokinetics and Pharmacodynamics of Emicizumab in Participants With Mild or Moderate Hemophilia A Without FVIII Inhibitors

NCT04158648

Conditions
Blood Coagulation Disorders, Blood Coagulation Disorders, Inherited, Coagulation Protein Disorders, +8 more
Locations
  • Childrens Hospital LA Los Angeles, California, United States
  • Hemophilia of Georgia Center for Bleeding & Clotting Disorders Atlanta, Georgia, United States
  • Indiana Hemophilia & Thrombosis center Indianapolis, Indiana, United States
  • University of Michigan, C.S. Mott Children's Hospital Ann Arbor, Michigan, United States
View all 22 locations
View Trial Details
Completed

Prophylaxis Regimen for Hemophilia A Patients

NCT05036278

Conditions
Blood Coagulation Disorders, Blood Coagulation Disorders, Inherited, Coagulation Protein Disorders, +7 more
Locations
  • Dr. Akshat Jain - Loma Linda University Medical Center Loma Linda, California, United States
  • Loma Linda University Children's Hospital - Hematology / Oncology Loma Linda, California, United States
  • Luskin Orthopaedic Institute for Children Los Angeles, California, United States
  • University of Colorado | Renal Research Office Aurora, Colorado, United States
View Trial Details
Completed

A Study to Evaluate Prospective Efficacy and Safety Data of Current FIX Prophylaxis Replacement Therapy in Adult Hemophilia B Subjects (FIX:C≤2%) or Current FVIII Prophylaxis Replacement Therapy in Adult Hemophilia A Subjects (FVIII:C≤1%)

NCT03587116

Conditions
Blood Coagulation Disorders, Blood Coagulation Disorders, Inherited, Coagulation Protein Disorders, +8 more
Locations
  • Clinical and Translational Research Unit (CTRU) Palo Alto, California, United States
  • Lucile Packard Childrens Hospital Palo Alto, California, United States
  • University of California, San Francisco - Outpatient Hematology Clinic San Francisco, California, United States
  • Stanford Health Care Stanford, California, United States
View all 75 locations
View Trial Details
Completed

Study to Evaluate the Efficacy and Safety of Valoctocogene Roxaparvovec, With Prophylactic Steroids in Hemophilia A

NCT04323098

Conditions
Blood Coagulation Disorders, Blood Coagulation Disorders, Inherited, Cardiovascular Diseases, +9 more
Locations
  • University of California Davis Health Sacramento, California, United States
  • Washington University School of Medicine St Louis, Missouri, United States
  • Nationwide Children's Hospital Columbus, Ohio, United States
  • The Royal Adelaide Hospital Adelaide, Australia
View Trial Details
Completed

A Study of Recombinant AAV2/6 Human Factor 8 Gene Therapy SB-525 (PF-07055480) in Subjects With Severe Hemophilia A

NCT03061201

Conditions
Blood Coagulation Disorders, Blood Coagulation Disorders, Inherited, Coagulation Protein Disorders, +6 more
Locations
  • Arkansas Children's Hospital Little Rock, Arkansas, United States
  • City of Hope Medical Center Duarte, California, United States
  • Midtown Ambulatory Care Center Sacramento, California, United States
  • UC Davis Ambulatory Care Clinic Sacramento, California, United States
View all 22 locations
View Trial Details
Completed

A Study of BAX 888 in Male Adults With Severe Hemophilia A

NCT03370172

Conditions
Blood Coagulation Disorders, Blood Coagulation Disorders, Inherited, Coagulation Protein Disorders, +6 more
Locations
  • Phoenix Childrens Hospital Phoenix, Arizona, United States
  • Orthopaedic Hospital DBA Orthopaedic Hemophilia Treatment Center Los Angeles, California, United States
  • UC Davis Medical Center Sacramento, California, United States
  • University of Colorado Hemophilia & Thrombosis Center Aurora, Colorado, United States
View all 26 locations
View Trial Details
Completed

Safety, Efficacy and PK of BIVV001 in Pediatric Patients With Hemophilia A

NCT04759131

Conditions
Blood Coagulation Disorders, Blood Coagulation Disorders, Inherited, Coagulation Protein Disorders, +6 more
Locations
  • Children's Hospital Los Angeles-Site Number:8400006 Los Angeles, California, United States
  • University of Florida-Site Number:8400009 Gainesville, Florida, United States
  • Children's Healthcare of Atlanta-Site Number:8400019 Atlanta, Georgia, United States
  • Rush University Medical Center-Site Number:8400001 Chicago, Illinois, United States
View all 40 locations
View Trial Details
Completed

Real World Use of Emicizumab in Infants and Children Ages 0-3 Years With Hemophilia A

NCT05248594

Conditions
Blood Coagulation Disorders, Blood Coagulation Disorders, Inherited, Coagulation Protein Disorders, +6 more
Locations
  • Connecticut Children's Hemophilia Treatment Center - Connecticut Children's Medical Center Hartford, Connecticut, United States
  • Yale Hemophilia Treatment Center New Haven, Connecticut, United States
  • Dartmouth Hitchcock Hemophilia Center - Mary Hitchcock Memorial Hospital Lebanon, New Hampshire, United States
  • Newark Beth Israel Newark, New Jersey, United States
View Trial Details

Related conditions